MVA Investors, LLC

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2024-07-02	2024-07-02	Tango Therapeutics Inc (TNGX)	S Sale	95,000 -46.6% 8.68 USD 824,600	95,000 -46.6%	8.68	USD 824,600
2024-07-02	2024-07-01	Tango Therapeutics Inc (TNGX)	S Sale	110,731 -35.2% 8.87 USD 982,184	110,731 -35.2%	8.87	USD 982,184
2024-07-02	2024-06-28	Tango Therapeutics Inc (TNGX)	S Sale	29,000 -8.4% 8.57 USD 248,530	29,000 -8.4%	8.57	USD 248,530
2024-06-07	2024-06-07	Tango Therapeutics Inc (TNGX)	S Sale	77,000 -18.3% 6.88 USD 529,760	77,000 -18.3%	6.88	USD 529,760
2024-06-07	2024-06-06	Tango Therapeutics Inc (TNGX)	S Sale	63,000 -13.0% 7.24 USD 456,120	63,000 -13.0%	7.24	USD 456,120
2024-05-03	2024-05-03	Tango Therapeutics Inc (TNGX)	S Sale	60,000 -11.0% 7.61 USD 456,600	60,000 -11.0%	7.61	USD 456,600
2024-05-03	2024-05-02	Tango Therapeutics Inc (TNGX)	S Sale	75,000 -12.1% 7.56 USD 567,000	75,000 -12.1%	7.56	USD 567,000
2024-05-03	2024-05-01	Tango Therapeutics Inc (TNGX)	S Sale	75,000 -10.8% 7.43 USD 557,250	75,000 -10.8%	7.43	USD 557,250
2023-02-13	2023-02-10	Tyra Biosciences Inc (TYRA)	S Sale	65,568 -74.4% 13.40 USD 878,611	65,568 -74.4%	13.40	USD 878,611
2023-02-13	2023-02-09	Tyra Biosciences Inc (TYRA)	S Sale	200,000 -69.4% 13.10 USD 2,620,000	200,000 -69.4%	13.10	USD 2,620,000